Vedere Bio logo

Vedere Bio

Cambridge, MA

Vedere is developing cutting-edge gene therapy products to restore functional vision to patients who have suffered vision loss from Inherited Retinal Degenerations (IRDs), as well as other causes of both genetic and non-genetic vision loss. While the vast majority of ocular gene therapies only limit the rate of inevitable vision loss, we aim to restore lost vision regardless of a patient’s underlying genetics or their stage of disease.

vederebio.com

Company Details

Founded

2019

Employees

Between 10 - 50 employees

Raised

$98,000,000

Headquarters Location

Cambridge, MA

Public

No

Acquired

Yes

CEO

Cyrus D. MozayeniCyrus D. Mozayeni

Founders

Cyrus Mozayeni
Cyrus Mozayeni

Company Collections

These are collections Vedere Bio is a part of. Click on the collection name to view similar companies.

Vedere Bio's Industries

Vedere Bio's Tech Stack